Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.43 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.43 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.43 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2029681 | 0.97 | KDM4E (0.55) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| SCHEMBL28569684 | 0.97 | KDM4E (0.55) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| SCHEMBL20836564 | 0.97 | KDM4E (0.55) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| SCHEMBL5569558 | 0.97 | KDM4E (0.55) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| SCHEMBL453216 | 0.97 | KDM4E (0.55) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| SCHEMBL30541972 | 0.97 | KDM4E (0.55) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| SCHEMBL15871737 | 0.97 | KDM4E (0.55) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| SCHEMBL28390061 | 0.94 | KDM4E (0.52) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| Bromide SCHEMBL15105223 | 0.94 | KDM4E (0.52) | KDM4EMAPK1HIF1APRMT1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10908949 | 0.94 | KDM4E (0.52) | KDM4EMAPK1HIF1APRMT1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2841496-B1 | RUBBER COMPOSITIONS | ALLNEX GERMANY GMBH (DE) | 2022-10-26 | — | — | EP | claimed |
| EP-3577149-B1 | METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-02-09 | — | — | EP | claimed |
| EP-3256508-B1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-27 | — | — | EP | claimed |
| US-6992149-B2 | Use of carbamate-modified aminoplast resins to improve the appearance and performance of powder coatings | BASF CORPORATION (US) | 2006-01-31 | — | — | US | claimed |
| US-20050182189-A1 | Use of carbamate-modified aminoplast resins to improve the appearance and performance of powder coatings | BASF CORPORATION | 2005-08-18 | — | — | US | claimed |
| EP-1564252-A1 | Use of carbamate-modified aminoplast resins to improve the appearance and performance of powder coatings | BASF CORPORATION (US) | 2005-08-17 | — | — | EP | claimed |
| EP-1159360-B1 | PARTICULATE CARBAMATE FUNCTIONAL COMPOUNDS AND POWDER COATINGS COMPRISING THE SAME | BASF CORP (US) | 2004-08-18 | — | — | EP | claimed |
| EP-1159361-B1 | POWDER SLURRY COATING COMPOSITION CONTAINING PARTICULATE CARBAMATE FUNCTIONAL COMPOUNDS AND A LIQUID COMPONENT | BASF CORP (US) | 2002-10-02 | — | — | EP | claimed |
| EP-0028204-B1 | PRE-EXTENDED ETHERIFIED AMINOPLAST RESINS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN SURFACE COATINGS | CIBA-GEIGY AG (CH) | 1984-02-29 | — | — | EP | claimed |
| EP-0011049-B1 | AMINOPLAST RESIN, ITS PREPARATION AND ITS USE | CIBA-GEIGY AG (CH) | 1982-08-04 | — | — | EP | claimed |
| EP-0028204-A2 | Pre-extended etherified aminoplast resins, process for their preparation and their use in surface coatings | CIBA-GEIGY AG (CH) | 1981-05-06 | — | — | EP | claimed |
| EP-0011049-A1 | Aminoplast resin, its preparation and its use | CIBA-GEIGY AG (CH) | 1980-05-14 | — | — | EP | claimed |
| US-20240398963-A1 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | COVAL BIOPHARMA (SHANGHAI) CO., LTD. (CN) | 2024-12-05 | — | — | US | disclosed |
| US-20230212110-A1 | CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2023-07-06 | — | — | US | disclosed |
| EP-4169901-A1 | CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD | National Institute Of Advanced Industrial Science and Technology (JP) | 2023-04-26 | — | — | EP | disclosed |
| CN-109476648-B | Sevelamer antibody-drug conjugates and methods of use | 豪夫迈·罗氏有限公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-0044274-A2 | Photopolymerisation by means of carbamoylsulfoxonium salts | CIBA-GEIGY AG (CH) | 1982-01-20 | — | — | EP | disclosed |
| EP-0035969-A1 | Composition of cationically polymerisable material and a catalyst | CIBA-GEIGY AG (CH) | 1981-09-16 | — | — | EP | disclosed |
| EP-0028204-A2 | Pre-extended etherified aminoplast resins, process for their preparation and their use in surface coatings | CIBA-GEIGY AG (CH) | 1981-05-06 | — | — | EP | disclosed |
| EP-0011049-A1 | Aminoplast resin, its preparation and its use | CIBA-GEIGY AG (CH) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212110-A1 | CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD | CPS1, ATM, OAT | KDM4E 933/4885MAPK1 2574/4885HIF1A 2038/4885 |
| US-20240398963-A1 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | TIE1, KDR, TEK | KDM4E 4486/4885MAPK1 4649/4885HIF1A 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.